So what is going to happen to Onyx reps next year- with so many quitting what will they do? Will there be a re-structure and everyone gets new managers? If so, why are the rest of ONYX reps staying?
The only onyx reps tht are staying are the crappy ones who can't get jobs elsewhere. They are losers just like the PCP Amgen OBU reps. They are people who can't get innovative therapeutic onc drugs at other companies. All of residual onyx will be RIFFed next year in favor of Amgen reps from other business units.
Don't you get it. The more of you that leave. The cheaper it is for Amgen. They want you to leave. Amgen OBU will be re-org with Onyx, and Amgen leadership will take over all of your region directors and district manager jobs. Your remaining leadership Will be taken out in favor of ours. Amgen OBU is waiting to abuse you little shits. Better leave or you will be treated worse than garbage.
Amgen is further cut cost by merging Onyx and the OBU. Since their will only be one regional director, and one DM per territory, Onyx DMs and Directors will be replaced by OBU ones. Open territories hires will be up to OBU leaders not Onyx. Amgen expects no more than the 15% of Onyx reps to stay with Amgen over the next 2 years.
OBU leadership has biting at the chomps to replace all of Onyx with trusted Amgen OBU reps and teams. All believe Kyprolis is under achieving due to Onyx incompetence.
Amgen needs to hit $3B in revenue to justify the acquisition and the $500mm in likely revenue from Kyprolis this year is well behind the growth and ramp up expectations. Although Onyx is showing growth, the rate is well below expectations hence why OBU sought to get control of the asset because they are on the hook for how well Kyprolis performs. OBU will be given a pass for this year since it was under Onyx control half the year and in transition, but come next year when Onyx reps and management are released, if Kyprolis under performs, senior management will be getting nasty and looking to fire people. Azelby, Rolf, Paulson, Ludwig will all be under fire since senior management gave them the car keys and there will be no excuses for failure.
So basically they want Kyprolis sold by the reps in the field that work 10-2 and pick their kids up from bus stop. NICE! Oh and by reps with little to on oncology experience.
Oh and now contract Kyprolis- I forgot Amgen reps can't sell a product unless there is a contract and a financial gain for practices use- only real reps can sell a therapeutic without a contract. Don't forget that!
When OBU and Onyx are merged and we OBU get Kyprolis, we will show you how real sales happens. We will make this bitch a mega blockbuster that you Onyx hacks could never dream of. It's sickening that dumb start up companies who don't know any better hire you losers.
